U.S. Antimicrobial Susceptibilty Testing Market to 2032
Overview
The U.S. Antimicrobial Susceptibilty Testing Market is expected to reach a 2.36 USD Billion by 2032 and is projected to grow at a CAGR of 9.04% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.51
Forecast, 2032 (USD Billion)
2.36
CAGR, 2024 - 2032
9.04%
Report Coverage
U.S.
U.S. Antimicrobial Susceptibilty Testing Market 2018-2032 USD Billion
U.S. Antimicrobial Susceptibilty Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.51 USD Billion
- Projected Market Size (2032): 2.36 USD Billion
- CAGR (2025-2032): 9.04%
Key Findings of U.S. Antimicrobial Susceptibilty Testing Market
- The U.S. Antimicrobial Susceptibilty Testing Market was valued at 1.51 USD Billion in 2024.
- The U.S. Antimicrobial Susceptibilty Testing Market is likely to grow at a CAGR of 9.04% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Anti Bacterial Testing in Type Segment accounted for the largest share of the market with a revenue of 1.11 USD Billion
- The fastest growing segment Disk Diffusion in Method Segment grew Fastest with a CAGR of 11.03% during the forecast period from 2024 to 2032.
U.S. Antimicrobial Susceptibilty Testing Market Scope
U.S. Antimicrobial Susceptibilty Testing Market Segmentation & Scope
Distribution Channel
- Third Party Distributor
- Retail Sales
- Direct Sales
End User
- Others
- Research Centres and Academic Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology companies
- Diagnostic Laboratories
- Hospitals
Product Type
- Service & Software
- Consumables & Accessories
- Instruments
Application
- Others
- Epidemiology
- Drug Discovery and Development
- Clinical Diagnostics
Type
- Others
- Anti Fungal Testing
- Anti Bacterial Testing
Method
- Others
- Geneotypic Methods
- E-Test
- Mass Spectrometry Method
- Dilution
- Disk Diffusion
U.S. Antimicrobial Susceptibilty Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.51 USD Billion |
| Market Value in 2032 | 2.36 USD Billion |
| CAGR (2025-2032) | 9.04% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Product Type,Application,Type,Method |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 1.51 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,509.49 USD Million in 2024.
Segments and Scope
-
U.S. Antimicrobial Susceptibilty Testing Market to 2032, By Distribution Channel
- Direct Sales is the largest segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.07 USD Billion in the year 2024.
- Direct Sales is the Fastest growing segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 9.65 % in forecast period 2025-2032.
-
U.S. Antimicrobial Susceptibilty Testing Market to 2032, By End User
- Hospitals is the largest segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 779.99 USD Billion in the year 2024.
- Diagnostic Laboratories is the Fastest growing segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 9.12 % in forecast period 2025-2032.
-
U.S. Antimicrobial Susceptibilty Testing Market to 2032, By Product Type
- Instruments is the largest segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 853.59 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 9.97 % in forecast period 2025-2032.
-
U.S. Antimicrobial Susceptibilty Testing Market to 2032, By Application
- Clinical Diagnostics is the largest segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.07 USD Billion in the year 2024.
- Clinical Diagnostics is the Fastest growing segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 9.58 % in forecast period 2025-2032.
-
U.S. Antimicrobial Susceptibilty Testing Market to 2032, By Type
- Anti Bacterial Testing is the largest segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.11 USD Billion in the year 2024.
- Anti Bacterial Testing is the Fastest growing segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 9.49 % in forecast period 2025-2032.
-
U.S. Antimicrobial Susceptibilty Testing Market to 2032, By Method
- Disk Diffusion is the largest segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 637.62 USD Billion in the year 2024.
- Disk Diffusion is the Fastest growing segment in U.S. Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 11.03 % in forecast period 2025-2032.
U.S. Antimicrobial Susceptibilty Testing Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Mast Group Ltd. | |||
| Liofilchem S.r.l. | |||
| Thermo Fisher Scientific Inc. | |||
| Rosco Diagnostica A/S | |||
U.S. Antimicrobial Susceptibilty Testing Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Antimicrobial Susceptibilty Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Distribution Channel,End User,Product Type,Application,Type,Method.
U.S. Antimicrobial Susceptibilty Testing Market was valued at USD 1.51(Revenue in USD Billion) in 2020.
U.S. Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 9.04% during the forecast period of 2024 to 2032.
The Anti Bacterial Testing segment is expected to dominate the U.S. Antimicrobial Susceptibilty Testing Market, holding a largest market share of 1.11 USD Billion in 2024
Coming Soon....
U.S. Antimicrobial Susceptibilty Testing Market Scope
U.S. Antimicrobial Susceptibilty Testing Market Segmentation & Scope
Distribution Channel
- Third Party Distributor
- Retail Sales
- Direct Sales
End User
- Others
- Research Centres and Academic Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology companies
- Diagnostic Laboratories
- Hospitals
Product Type
- Service & Software
- Consumables & Accessories
- Instruments
Application
- Others
- Epidemiology
- Drug Discovery and Development
- Clinical Diagnostics
Type
- Others
- Anti Fungal Testing
- Anti Bacterial Testing
Method
- Others
- Geneotypic Methods
- E-Test
- Mass Spectrometry Method
- Dilution
- Disk Diffusion
Frequently Asked Questions
The U.S. Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Distribution Channel,End User,Product Type,Application,Type,Method.
U.S. Antimicrobial Susceptibilty Testing Market was valued at USD 1.51(Revenue in USD Billion) in 2020.
U.S. Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 9.04% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Antimicrobial Susceptibilty Testing Market for final year is USD 2.36 (USD Billion).
U.S. Antimicrobial Susceptibilty Testing Market Company Profiling
Frequently Asked Questions
The U.S. Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Distribution Channel,End User,Product Type,Application,Type,Method.
U.S. Antimicrobial Susceptibilty Testing Market was valued at USD 1.51(Revenue in USD Billion) in 2020.
U.S. Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 9.04% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Antimicrobial Susceptibilty Testing Market for final year is USD 2.36 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.